Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FYBGC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,234
Award facts
- Contract value 100% obligated
- $3,234.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,234.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 200-unit vials of BOTOX. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical supply support through multiple regional prime vendor contractors. Under this contract vehicle, DMS Pharmaceutical Group is authorized to supply a broad range of pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. The contractor's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, with this particular delivery order for BOTOX supporting recurring medical supply needs across the Defense Department's healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FYBGC?
SPE2DB26FYBGC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FYBGC worth?
The government has obligated $3,234 on SPE2DB26FYBGC.
Is contract SPE2DB26FYBGC an order under another contract?
Yes. SPE2DB26FYBGC is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB26FYBGC competed?
The extent of competition for SPE2DB26FYBGC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award